skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 441  for All Library Resources

Results 1 2 3 4 5 next page
Show only
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Dapagliflozin is associated with lower risk of cardiovascular events and all-cause mortality in people with type 2 diabetes (CVD-REAL Nordic) when compared with dipeptidyl peptidase-4 inhibitor therapy: A multinational observational study
Material Type:
Article
Add to My Research

Dapagliflozin is associated with lower risk of cardiovascular events and all-cause mortality in people with type 2 diabetes (CVD-REAL Nordic) when compared with dipeptidyl peptidase-4 inhibitor therapy: A multinational observational study

Diabetes, obesity & metabolism, 2018-02, Vol.20 (2), p.344

2017 The Authors. Diabetes, Obesity and Metabolism published by John Wiley & Sons Ltd. ;ISSN: 1463-1326 ;EISSN: 1463-1326 ;DOI: 10.1111/dom.13077 ;PMID: 28771923

Digital Resources/Online E-Resources

2
The Swedish CArdioPulmonary BioImage Study: objectives and design
Material Type:
Article
Add to My Research

The Swedish CArdioPulmonary BioImage Study: objectives and design

Journal of internal medicine, 2015-12, Vol.278 (6), p.645-659 [Peer Reviewed Journal]

2015 The Authors. Journal of Internal Medicine published by John Wiley & Sons Ltd on behalf of Association for Publication of The Journal of Internal Medicine. ;ISSN: 0954-6820 ;ISSN: 1365-2796 ;EISSN: 1365-2796 ;DOI: 10.1111/joim.12384 ;PMID: 26096600

Digital Resources/Online E-Resources

3
Severity of Cardiovascular Disease Outcomes Among Patients With HIV Is Related to Markers of Inflammation and Coagulation
Material Type:
Article
Add to My Research

Severity of Cardiovascular Disease Outcomes Among Patients With HIV Is Related to Markers of Inflammation and Coagulation

Journal of the American Heart Association, 2014-05, Vol.3 (3), p.e000844-n/a [Peer Reviewed Journal]

2014 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley Blackwell. ;cc-by-nc (c) Nordell, Anna D. et al., 2014 info:eu-repo/semantics/openAccess http://creativecommons.org/licenses/by-nc/3.0/es ;2014 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley Blackwell. 2014 ;ISSN: 2047-9980 ;EISSN: 2047-9980 ;DOI: 10.1161/JAHA.114.000844 ;PMID: 24870935

Full text available

4
Cardiorenal outcomes by indices of liver steatosis and fibrosis in individuals with type 2 diabetes and atherosclerotic cardiovascular disease: Analyses from VERTIS CV, a randomized trial of the sodium-glucose cotransporter-2 inhibitor ertugliflozin
Material Type:
Article
Add to My Research

Cardiorenal outcomes by indices of liver steatosis and fibrosis in individuals with type 2 diabetes and atherosclerotic cardiovascular disease: Analyses from VERTIS CV, a randomized trial of the sodium-glucose cotransporter-2 inhibitor ertugliflozin

Diabetes, obesity & metabolism, 2023-03, Vol.25 (3), p.758

2022 Merck Sharp & Dohme LLC and Pfizer Inc. Diabetes, Obesity and Metabolism published by John Wiley & Sons Ltd. ;ISSN: 1463-1326 ;EISSN: 1463-1326 ;DOI: 10.1111/dom.14923 ;PMID: 36394384

Digital Resources/Online E-Resources

5
Model-based predictions on health benefits and budget impact of implementing empagliflozin in people with type 2 diabetes and established cardiovascular disease
Material Type:
Article
Add to My Research

Model-based predictions on health benefits and budget impact of implementing empagliflozin in people with type 2 diabetes and established cardiovascular disease

Diabetes, obesity & metabolism, 2023-03, Vol.25 (3), p.748

2022 The Authors. Diabetes, Obesity and Metabolism published by John Wiley & Sons Ltd. ;ISSN: 1462-8902 ;ISSN: 1463-1326 ;EISSN: 1463-1326 ;DOI: 10.1111/dom.14921 ;PMID: 36371543

Digital Resources/Online E-Resources

6
How representative of a general type 2 diabetes population are patients included in cardiovascular outcome trials with SGLT2 inhibitors? A large European observational study
Material Type:
Article
Add to My Research

How representative of a general type 2 diabetes population are patients included in cardiovascular outcome trials with SGLT2 inhibitors? A large European observational study

Diabetes, obesity & metabolism, 2019-04, Vol.21 (4), p.968

2018 The Authors. Diabetes, Obesity and Metabolism published by John Wiley & Sons Ltd. ;info:eu-repo/semantics/openAccess ;ISSN: 1462-8902 ;ISSN: 1463-1326 ;EISSN: 1463-1326 ;DOI: 10.1111/dom.13612 ;PMID: 30537226

Digital Resources/Online E-Resources

7
Previous pre-eclampsia, gestational diabetes mellitus and the risk of cardiovascular disease: A nested case-control study in Sweden
Material Type:
Article
Add to My Research

Previous pre-eclampsia, gestational diabetes mellitus and the risk of cardiovascular disease: A nested case-control study in Sweden

BJOG : an international journal of obstetrics and gynaecology, 2023-09, Vol.130 (10), p.1209 [Peer Reviewed Journal]

2023 The Authors. BJOG: An International Journal of Obstetrics and Gynaecology published by John Wiley & Sons Ltd. ;ISSN: 1471-0528 ;ISSN: 1470-0328 ;EISSN: 1471-0528 ;DOI: 10.1111/1471-0528.17454 ;PMID: 36974033

Digital Resources/Online E-Resources

8
NT-proBNP by Itself Predicts Death and Cardiovascular Events in High-Risk Patients With Type 2 Diabetes Mellitus
Material Type:
Article
Add to My Research

NT-proBNP by Itself Predicts Death and Cardiovascular Events in High-Risk Patients With Type 2 Diabetes Mellitus

Journal of the American Heart Association, 2020-10, Vol.9 (19), p.e017462-e017462 [Peer Reviewed Journal]

2020 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. ;ISSN: 2047-9980 ;EISSN: 2047-9980 ;DOI: 10.1161/JAHA.120.017462 ;PMID: 32964800

Full text available

9
Novel oral glucose-lowering drugs are associated with lower risk of all-cause mortality, cardiovascular events and severe hypoglycaemia compared with insulin in patients with type 2 diabetes
Material Type:
Article
Add to My Research

Novel oral glucose-lowering drugs are associated with lower risk of all-cause mortality, cardiovascular events and severe hypoglycaemia compared with insulin in patients with type 2 diabetes

Diabetes, obesity & metabolism, 2017-06, Vol.19 (6), p.831

2017 The Authors. Diabetes, Obesity and Metabolism published by John Wiley & Sons Ltd. ;ISSN: 1462-8902 ;ISSN: 1463-1326 ;EISSN: 1463-1326 ;DOI: 10.1111/dom.12889 ;PMID: 28116795

Digital Resources/Online E-Resources

10
Dapagliflozin and cardiovascular mortality and disease outcomes in a population with type 2 diabetes similar to that of the DECLARE-TIMI 58 trial: A nationwide observational study
Material Type:
Article
Add to My Research

Dapagliflozin and cardiovascular mortality and disease outcomes in a population with type 2 diabetes similar to that of the DECLARE-TIMI 58 trial: A nationwide observational study

Diabetes, obesity & metabolism, 2019-05, Vol.21 (5), p.1136

2019 The Authors. Diabetes, Obesity and Metabolism published by John Wiley & Sons Ltd. ;ISSN: 1462-8902 ;ISSN: 1463-1326 ;EISSN: 1463-1326 ;DOI: 10.1111/dom.13627 ;PMID: 30609272

Digital Resources/Online E-Resources

11
Twenty years on from the introduction of the high risk strategy for stroke and cardiovascular disease prevention: a systematic scoping review
Material Type:
Article
Add to My Research

Twenty years on from the introduction of the high risk strategy for stroke and cardiovascular disease prevention: a systematic scoping review

European journal of neurology, 2024-03, Vol.31 (3), p.e16157-n/a [Peer Reviewed Journal]

2023 The Authors. published by John Wiley & Sons Ltd on behalf of European Academy of Neurology. ;2023 The Authors. European Journal of Neurology published by John Wiley & Sons Ltd on behalf of European Academy of Neurology. ;2023. This article is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1351-5101 ;EISSN: 1468-1331 ;DOI: 10.1111/ene.16157 ;PMID: 38009814

Digital Resources/Online E-Resources

12
What Is the Best Mix of Population-Wide and High-Risk Targeted Strategies of Primary Stroke and Cardiovascular Disease Prevention?
Material Type:
Article
Add to My Research

What Is the Best Mix of Population-Wide and High-Risk Targeted Strategies of Primary Stroke and Cardiovascular Disease Prevention?

Journal of the American Heart Association, 2020-02, Vol.9 (3), p.e014494 [Peer Reviewed Journal]

2020 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. ;ISSN: 2047-9980 ;EISSN: 2047-9980 ;DOI: 10.1161/jaha.119.014494 ;PMID: 31983323

Full text available

13
The comparative cardiovascular and renal effectiveness of sodium-glucose co-transporter-2 inhibitors and glucagon-like peptide-1 receptor agonists: A Scandinavian cohort study
Material Type:
Article
Add to My Research

The comparative cardiovascular and renal effectiveness of sodium-glucose co-transporter-2 inhibitors and glucagon-like peptide-1 receptor agonists: A Scandinavian cohort study

Diabetes, obesity & metabolism, 2022-03, Vol.24 (3), p.473

2021 The Authors. Diabetes, Obesity and Metabolism published by John Wiley & Sons Ltd. ;ISSN: 1463-1326 ;EISSN: 1463-1326 ;DOI: 10.1111/dom.14598 ;PMID: 34738703

Digital Resources/Online E-Resources

14
Per- and polyfluoroalkyl substances and cardiometabolic diseases: A review
Material Type:
Article
Add to My Research

Per- and polyfluoroalkyl substances and cardiometabolic diseases: A review

Basic & clinical pharmacology & toxicology, 2024-01, Vol.134 (1), p.141 [Peer Reviewed Journal]

2023 The Authors. Basic & Clinical Pharmacology & Toxicology published by John Wiley & Sons Ltd on behalf of Nordic Association for the Publication of BCPT (former Nordic Pharmacological Society). ;ISSN: 1742-7843 ;EISSN: 1742-7843 ;DOI: 10.1111/bcpt.13949 ;PMID: 37817473

Digital Resources/Online E-Resources

15
Systemic lupus erythematosus and cardiovascular disease
Material Type:
Article
Add to My Research

Systemic lupus erythematosus and cardiovascular disease

Journal of internal medicine, 2023-01, Vol.293 (1), p.48-62 [Peer Reviewed Journal]

2022 The Authors. published by John Wiley & Sons Ltd on behalf of Association for Publication of The Journal of Internal Medicine. ;2022 The Authors. Journal of Internal Medicine published by John Wiley & Sons Ltd on behalf of Association for Publication of The Journal of Internal Medicine. ;2022. This article is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 0954-6820 ;ISSN: 1365-2796 ;EISSN: 1365-2796 ;DOI: 10.1111/joim.13557 ;PMID: 35982610

Digital Resources/Online E-Resources

16
Lower cardiorenal risk with sodium-glucose cotransporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes without cardiovascular and renal diseases: A large multinational observational study
Material Type:
Article
Add to My Research

Lower cardiorenal risk with sodium-glucose cotransporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes without cardiovascular and renal diseases: A large multinational observational study

Diabetes, obesity & metabolism, 2021-01, Vol.23 (1), p.75

2020 The Authors. Diabetes, Obesity and Metabolism published by John Wiley & Sons Ltd. ;ISSN: 1463-1326 ;EISSN: 1463-1326 ;DOI: 10.1111/dom.14189 ;PMID: 32893440

Digital Resources/Online E-Resources

17
Extracellular vesicles and their non-coding RNA cargos: Emerging players in cardiovascular disease
Material Type:
Article
Add to My Research

Extracellular vesicles and their non-coding RNA cargos: Emerging players in cardiovascular disease

The Journal of physiology, 2023-11, Vol.601 (22), p.4989-5009 [Peer Reviewed Journal]

2022 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society. ;2022. This article is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 0022-3751 ;ISSN: 1469-7793 ;EISSN: 1469-7793 ;DOI: 10.1113/JP283200 ;PMID: 36094621

Digital Resources/Online E-Resources

18
Self‐reported symptoms of sleep‐disordered breathing and risk of cardiovascular diseases: Observational and Mendelian randomization findings
Material Type:
Article
Add to My Research

Self‐reported symptoms of sleep‐disordered breathing and risk of cardiovascular diseases: Observational and Mendelian randomization findings

Journal of sleep research, 2022-12, Vol.31 (6), p.e13681-n/a [Peer Reviewed Journal]

2022 The Authors. published by John Wiley & Sons Ltd on behalf of European Sleep Research Society. ;2022 The Authors. Journal of Sleep Research published by John Wiley & Sons Ltd on behalf of European Sleep Research Society. ;ISSN: 0962-1105 ;ISSN: 1365-2869 ;EISSN: 1365-2869 ;DOI: 10.1111/jsr.13681 ;PMID: 35869582

Digital Resources/Online E-Resources

19
Pregnancy as an opportunity to prevent type 2 diabetes mellitus: FIGO Best Practice Advice
Material Type:
Article
Add to My Research

Pregnancy as an opportunity to prevent type 2 diabetes mellitus: FIGO Best Practice Advice

International journal of gynecology and obstetrics, 2023-01, Vol.160 Suppl 1 (S1), p.56 [Peer Reviewed Journal]

2023 The Authors. International Journal of Gynecology & Obstetrics published by John Wiley & Sons Ltd on behalf of International Federation of Gynecology and Obstetrics. ;ISSN: 0020-7292 ;ISSN: 1879-3479 ;EISSN: 1879-3479 ;DOI: 10.1002/ijgo.14537 ;PMID: 36635082

Digital Resources/Online E-Resources

20
Cardiovascular risk factors and lifestyle behaviours in relation to longevity: a Mendelian randomization study
Material Type:
Article
Add to My Research

Cardiovascular risk factors and lifestyle behaviours in relation to longevity: a Mendelian randomization study

Journal of internal medicine, 2021-02, Vol.289 (2), p.232-243 [Peer Reviewed Journal]

2020 The Authors. published by John Wiley & Sons Ltd on behalf of Association for Publication of The Journal of Internal Medicine ;2020 The Authors. Journal of Internal Medicine published by John Wiley & Sons Ltd on behalf of Association for Publication of The Journal of Internal Medicine. ;2020. This article is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 0954-6820 ;ISSN: 1365-2796 ;EISSN: 1365-2796 ;DOI: 10.1111/joim.13196 ;PMID: 33107078

Digital Resources/Online E-Resources

Results 1 - 20 of 441  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (419)

Refine My Results

Creation Date 

From To
  1. Before 2006  (5)
  2. 2006 To 2010  (5)
  3. 2011 To 2014  (23)
  4. 2015 To 2019  (104)
  5. After 2019  (305)
  6. More options open sub menu

Language 

  1. Japanese  (41)
  2. Norwegian  (10)
  3. French  (1)
  4. German  (1)
  5. Arabic  (1)
  6. More options open sub menu

Searching Remote Databases, Please Wait